{'fraction_non_alphanumeric': 0.034443817052512704, 'fraction_numerical': 0.014116318464144552, 'mean_word_length': 5.174216027874564, 'pattern_counts': {'":': 0, '<': 2, '<?xml version=': 0, '>': 1, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Association between time in range and postprandial glucose contribution rate in non-insulin-treated type 2 diabetic patients: Inverse correlation of time in range with postprandial glucose contribution rate.

BACKGROUND
Whether time in range (TIR), a parameter derived from continuous glucose monitoring (CGM), is a marker of postprandial hyperglycemia remains to be determined. Here we examined the association between TIR and postprandial glucose in non-insulin-treated type 2 diabetic patients.


METHODS
Our cross-sectional study included 729 non-insulin-treated patients with type 2 diabetes who underwent CGM without any changes in drug therapy on admission. The 24-hr CGM record was analyzed for average glucose, standard deviation, percentage coefficient of variation, time above range, TIR, time below range, area under the curve (AUC) of basal glucose, AUC of postprandial glucose, and postprandial glucose contribution rate (%). The primary endpoint was the association between TIR and the postprandial glucose contribution rate.


RESULTS
We made TIR groups divided into 10% increments for a 7-group and compared with <40% to > 90%. The basal and postprandial glucose AUCs correlated negatively with TIR. The postprandial glucose contribution rate correlated with TIR. The cutoff value for TIR, where postprandial glucose contribution rate was lower than the basal glucose contribution rate, was 66.3%.


CONCLUSIONS
In non-insulin-treated type 2 diabetic patients, postprandial glucose AUC was higher in the high TIR group, while the basal glucose AUC was higher in the low TIR group. Good glycemic control can be achieved with therapeutic interventions that target postprandial glucose and basal glucose in patients with TIR ≥66.3% and <66.3%, respectively.